1.
Southeast Asian J Trop Med Public Health
;
1979 Sep; 10(3): 385-8
Artículo
en Inglés
| IMSEAR
| ID: sea-34502
RESUMEN
Clinical studies in the treatment of 54 children suffering from DHF with a combination of dipyridamole and ASA as an adjuvant of our standard therapy consisted of fluid, electrolytes, blood, plasma and plasma expanders were evaluated. Heparin was administered in cases of DIC. It appeared that dipyridamole and ASA did not change the mortality significantly, but it prevented the progress of the severity of the disease from grade I and II to grade III and IV.